Buscar
-
Two rhombomeres are altered in Hoxa-1 mutant mice.
(Development (Cambridge, England). vol. 119, n° 2, pp. 319-38, 1993-10-01)Article de revue -
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies
(University of Chicago Press, 2019)Chapitre d'ouvrage -
Institutionnalisation des politiques publiques de santé & diffusion de l’innovation médicale
(Colloque «Science, innovation, technique & société» RT-29 Asso. Fr. Sociologie,, FR, Bordeaux)Communication dans un congrès avec actes -
The scientific-knowledge based institutionalization of Health Technology Assessment: a bibliometric and network analysis
(10th Annual Meeting HTAi, KR, Seoul)Communication dans un congrès avec actes -
The political construction of orphan drugs market: between innovation & access to care
(DIME workshop innovation & inequality, IT, PISE, 2010)Communication dans un congrès avec actes -
Orphan Drug Market Exclusivity Extension versus Patent Monopoly
(7th Annual Conference of the American Society of Health Economists, US, Atlanta)Communication dans un congrès avec actes -
Naming institution after neologism as marker of the institutionalization of new discipline
(4S Annual Meeting – Society for Social Sciences Studies, AU, Sidney)Communication dans un congrès avec actes -
Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants.
(Development (Cambridge, England). vol. 120, n° 10, pp. 2749-71, 1994-10-01)Article de revue -
Sin título
(Development (Cambridge, England). vol. 121, n° 2, pp. 539-48, 1995-02-01)Article de revue